Immuno-biology of Chikungunya and implications for disease intervention.
about
Antiviral immunity of Anopheles gambiae is highly compartmentalized, with distinct roles for RNA interference and gut microbiotaγδ T Cells Play a Protective Role in Chikungunya Virus-Induced DiseaseChikungunya vaccines in developmentHLA Class I Restriction as a Possible Driving Force for Chikungunya EvolutionViperin restricts chikungunya virus replication and pathology.Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor libraryEarly neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.In silico prediction of the granzyme B degradomeCytokines in acute chikungunya.Sero-prevalence and cross-reactivity of chikungunya virus specific anti-E2EP3 antibodies in arbovirus-infected patientsNeutralization activity of patient sera collected during the 2008-2009 Chikungunya outbreak in Thailand.Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody responseCombined miRNA and mRNA signature identifies key molecular players and pathways involved in chikungunya virus infection in human cells.Chikungunya virus exploits miR-146a to regulate NF-κB pathway in human synovial fibroblasts.Chikungunya and dengue fever among hospitalized febrile patients in northern TanzaniaEarly appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection.Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection.The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.Emergence and clinical insights into the pathology of Chikungunya virus infection.Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology.Age has a role in driving host immunopathological response to alphavirus infection.Differential proteome analysis of Chikungunya virus-infected new-born mice tissues reveal implication of stress, inflammatory and apoptotic pathways in disease pathogenesis.Chikungunya virus: clinical aspects and treatment - A Review.Association of human leukocyte antigen class II allele and haplotypes in chikungunya viral infection in a western Indian population.Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice.Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study.Limitations of Current in Vivo Mouse Models for the Study of Chikungunya Virus Pathogenesis.Chikungunya Virus: Pathophysiology, Mechanism, and Modeling.
P2860
Q24701764-9DEC58B7-05B2-4506-8032-6C7EBE226324Q26314703-63EC7F46-FFF0-4315-842B-CD27F739C6EDQ26700081-D045A1E2-7D60-4C4F-8CA9-2753BCCA0A60Q27490985-ADFE6B3C-FB8B-4073-8B9A-980C0EBB49CBQ28504479-0EA89B00-1EC0-47EA-82CD-1923F19A34FEQ28534763-3939DE95-EE39-494B-A831-8F63618ED8DDQ30516488-2157F2A2-1266-4433-938E-AED841F7B1B0Q34113650-1E931B7B-32C5-4508-9359-C80A50EBE256Q34222770-66C03985-9B93-44D5-80C1-DDD866279C97Q34400952-800C4A6C-A206-489F-A699-BE6A15AA394DQ34875480-9399E535-6D86-414E-A0A8-B548ECFFBF59Q34916476-7F22B5DC-F15D-4662-8F7C-D164E1341508Q35023852-99225036-F1EB-40F2-AD3C-DCAAD94536D7Q35053333-DC5159F5-5752-478D-950C-4523EA81B825Q35217077-AEA51A97-BD4C-4FBE-9631-3B5D2955BD0BQ35637100-CA02D832-C80E-4B0C-9AAD-415A9455A410Q35808631-4689AFF0-F82D-4425-8816-1930DEEE9700Q36826708-7EDCD084-8DD4-4F7E-8337-77838F2A1D0CQ37347319-74358222-EAD9-464D-A04F-9D15F81C6BE8Q37643733-096D87E4-2680-42E0-9899-F56BBC55FDD1Q37785544-E4DEC569-7D02-43C7-91C2-15314F418E2CQ37993737-92E47ADB-D1BD-43DB-A948-4C0CE211DE9CQ39458858-D6F27D71-1364-46D3-97CC-C364865DF0ACQ39562528-B69A8E9E-07A3-4169-AC72-01F9B18F2AFCQ40098030-B04BA064-34B7-41BF-82EB-06F17C615269Q40211679-2FAAB443-95BB-464C-9307-DF7202EB9E1BQ40254655-1F0EF50E-AE1B-4BC2-97B1-28133704C9F1Q40318152-DC3DCB9D-00C0-4F30-BD21-7AAE4BAA9FC3Q42705670-5D8773A0-C9A0-4D5A-A512-76DABE58AE3EQ44843465-AD09DB42-9644-4498-8D3C-AE5CBDAC1FC6
P2860
Immuno-biology of Chikungunya and implications for disease intervention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immuno-biology of Chikungunya and implications for disease intervention.
@en
Immuno-biology of Chikungunya and implications for disease intervention.
@nl
type
label
Immuno-biology of Chikungunya and implications for disease intervention.
@en
Immuno-biology of Chikungunya and implications for disease intervention.
@nl
prefLabel
Immuno-biology of Chikungunya and implications for disease intervention.
@en
Immuno-biology of Chikungunya and implications for disease intervention.
@nl
P50
P1476
Immuno-biology of Chikungunya and implications for disease intervention.
@en
P2093
Edward K S Ong
Joo-Chuan Tong
P304
P356
10.1016/J.MICINF.2009.09.003
P5008
P577
2009-09-06T00:00:00Z